SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-19-001492
Filing Date
2019-02-14
Accepted
2019-02-14 06:31:53
Documents
4

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT gtbp_s3.htm S-3 471953
2 OPINION ON LEGALITY gtbio_ex51.htm EX-5.1 10843
3 CONSENTS OF EXPERTS AND COUNSEL gtbio_ex231.htm EX-23.1 4857
4 IMAGE gtbio_img.jpg GRAPHIC 18030
  Complete submission text file 0001654954-19-001492.txt   513904
Mailing Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362
Business Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-229667 | Film No.: 19600526
SIC: 2834 Pharmaceutical Preparations